Beyazal, M. Et Al. 2016. Relationship of serum osteoprotegerin with arterial stiffness, preclinical atherosclerosis, and disease activity in patients with ankylosing spondylitis. CLINICAL RHEUMATOLOGY , vol.35, no.9 , 2235-2241.

Beyazal, M., ERDOGAN, T., TURKYILMAZ, A. K., DEVRIMSEL, G., CURE, M. C., BEYAZAL, M., ... SAHIN, I.(2016). Relationship of serum osteoprotegerin with arterial stiffness, preclinical atherosclerosis, and disease activity in patients with ankylosing spondylitis. CLINICAL RHEUMATOLOGY , vol.35, no.9, 2235-2241.

Beyazal, MÜNEVVER Et Al. "Relationship of serum osteoprotegerin with arterial stiffness, preclinical atherosclerosis, and disease activity in patients with ankylosing spondylitis," CLINICAL RHEUMATOLOGY , vol.35, no.9, 2235-2241, 2016

Beyazal, MÜNEVVER S. Et Al. "Relationship of serum osteoprotegerin with arterial stiffness, preclinical atherosclerosis, and disease activity in patients with ankylosing spondylitis." CLINICAL RHEUMATOLOGY , vol.35, no.9, pp.2235-2241, 2016

Beyazal, M. Et Al. (2016) . "Relationship of serum osteoprotegerin with arterial stiffness, preclinical atherosclerosis, and disease activity in patients with ankylosing spondylitis." CLINICAL RHEUMATOLOGY , vol.35, no.9, pp.2235-2241.

@article{article, author={MÜNEVVER SERDAROĞLU BEYAZAL Et Al. }, title={Relationship of serum osteoprotegerin with arterial stiffness, preclinical atherosclerosis, and disease activity in patients with ankylosing spondylitis}, journal={CLINICAL RHEUMATOLOGY}, year=2016, pages={2235-2241} }